BACKGROUND: Transgender women worldwide have the highest prevalence of HIV and the lowest access to prevention among groups at risk of HIV. However, few longitudinal studies have directly measured HIV incidence and identified predictors of HIV acquisition among transgender women. SETTING: São Paulo, Latin America's largest city. METHODS: We conducted a longitudinal study among transgender women in São Paulo. Participants were recruited by a long-chain peer referral process from May 2017 to July 2019. Those aged 18 years and older and who were HIV-negative at baseline were retested every 6 months up to 18 months. HIV incidence was calculated by dividing the number of seroconversions by the person-years (PYs) of follow-up; 95% confidence intervals (CIs) were constructed assuming a Poisson distribution. Conditional maximum likelihood ratios assessed differences in HIV incidence by risk factors. RESULTS: A racially/ethnically diverse sample of 545 HIV-negative transgender women was enrolled. In 485.5 PYs of follow-up, 13 seroconversions were observed, yielding an incidence of 2.68 per 100 PYs (95% CI: 1.43 to 4.58). HIV incidence was significantly higher among transgender women aged 18-24 years (rate ratio 3.85, 95% CI: 1.24 to 12.93) and among those who engaged in sex work in the preceding month (rate ratio 5.90, 95% CI: 1.71 to 26.62). CONCLUSIONS: HIV transmission continues at a high rate among transgender women in Brazil. Factors such as young age, lower level of education, and limited employment opportunities may lead to dependence on sex work that in turn increases HIV risk. Transgender-friendly prevention services, particularly programs delivering pre-exposure prophylaxis, are urgently needed.
BACKGROUND: Transgender women worldwide have the highest prevalence of HIV and the lowest access to prevention among groups at risk of HIV. However, few longitudinal studies have directly measured HIV incidence and identified predictors of HIV acquisition among transgender women. SETTING: São Paulo, Latin America's largest city. METHODS: We conducted a longitudinal study among transgender women in São Paulo. Participants were recruited by a long-chain peer referral process from May 2017 to July 2019. Those aged 18 years and older and who were HIV-negative at baseline were retested every 6 months up to 18 months. HIV incidence was calculated by dividing the number of seroconversions by the person-years (PYs) of follow-up; 95% confidence intervals (CIs) were constructed assuming a Poisson distribution. Conditional maximum likelihood ratios assessed differences in HIV incidence by risk factors. RESULTS: A racially/ethnically diverse sample of 545 HIV-negative transgender women was enrolled. In 485.5 PYs of follow-up, 13 seroconversions were observed, yielding an incidence of 2.68 per 100 PYs (95% CI: 1.43 to 4.58). HIV incidence was significantly higher among transgender women aged 18-24 years (rate ratio 3.85, 95% CI: 1.24 to 12.93) and among those who engaged in sex work in the preceding month (rate ratio 5.90, 95% CI: 1.71 to 26.62). CONCLUSIONS: HIV transmission continues at a high rate among transgender women in Brazil. Factors such as young age, lower level of education, and limited employment opportunities may lead to dependence on sex work that in turn increases HIV risk. Transgender-friendly prevention services, particularly programs delivering pre-exposure prophylaxis, are urgently needed.
Authors: Kate Shannon; Anna-Louise Crago; Stefan D Baral; Linda-Gail Bekker; Deanna Kerrigan; Michele R Decker; Tonia Poteat; Andrea L Wirtz; Brian Weir; Marie-Claude Boily; Jenny Butler; Steffanie A Strathdee; Chris Beyrer Journal: Lancet Date: 2018-07-20 Impact factor: 79.321
Authors: Beatriz Grinsztejn; Emilia M Jalil; Laylla Monteiro; Luciane Velasque; Ronaldo I Moreira; Ana Cristina F Garcia; Cristiane V Castro; Alícia Krüger; Paula M Luz; Albert Y Liu; Willi McFarland; Susan Buchbinder; Valdilea G Veloso; Erin C Wilson Journal: Lancet HIV Date: 2017-02-08 Impact factor: 12.767
Authors: Erin C Wilson; Emilia M Jalil; Ronaldo I Moreira; Luciane Velasque; Cristiane V Castro; Laylla Monteiro; Valdilea G Veloso; Beatriz Grinsztejn Journal: AIDS Care Date: 2020-11-15
Authors: Willi McFarland; Paul Wesson; Caitlin Turner; Jess Lin; Maria Amelia de Sousa Mascena Veras; Hongjing Yan; Henry F Raymond; Erin C Wilson Journal: J Acquir Immune Defic Syndr Date: 2020-05-01 Impact factor: 3.771
Authors: Theo Beltran; Amani M Allen; Jess Lin; Caitlin Turner; Emily J Ozer; Erin C Wilson Journal: Int J Environ Res Public Health Date: 2019-11-15 Impact factor: 3.390
Authors: Daniel Jason McCartney; Thiago Félix Pinheiro; José Luis Gomez; Paula Galdino Cardin de Carvalho; Maria Amélia Veras; Philippe Mayaud Journal: Braz J Infect Dis Date: 2022-05-02 Impact factor: 3.257
Authors: Sheri A Lippman; Jae M Sevelius; Gustavo Santa Roza Saggese; Hailey Gilmore; Katia Cristina Bassichetto; Daniel Dutra de Barros; Renata Batisteli de Oliveira; Luca Fasciolo Maschião; Dorothy Chen; Maria Amelia de Sousa Mascena Veras Journal: AIDS Behav Date: 2022-02-04